Cardiff Oncology, Inc. (CRDF) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
6/25
Growth 2
Margin 0
Expansion 3
Platform 0
Financial 1
latest quarter score
Earnings Reports
- 6